Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 38 | 1 | 3 | 0 | 968,60 € | 1.000,9 € | 3,34 % |
| Eli Lilly Corp. | 52 | 0 | 5 | 0 | 820,90 € | 788,80 € | -3,91 % |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 3 | 0 | 449,15 € | 428,60 € | -4,58 % |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | 368,10 € | 419,64 € | 14,00 % |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | 259,40 € | 315,00 € | 21,43 % |
| Amgen Inc. | 26 | 0 | 1 | 0 | 279,00 € | 297,31 € | 6,56 % |
| Biogen Inc. | 50 | 1 | 5 | 0 | 216,50 € | 293,22 € | 35,44 % |
| United Therapeutics | 21 | 0 | 3 | 0 | 269,10 € | 288,66 € | 7,27 % |
| Charles River Labs Intl | 11 | 0 | 1 | 0 | 195,70 € | 249,59 € | 27,54 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 149,85 € | 236,30 € | 57,69 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 159,28 € | 200,06 € | 25,60 % |
| Johnson & Johnson | 33 | 1 | 3 | 0 | 135,96 € | 195,31 € | 43,65 % |
| Krystal Biotech | 18 | 0 | 1 | 0 | 166,10 € | 180,00 € | 8,37 % |
| AbbVie Inc. | 23 | 0 | 2 | 0 | 157,50 € | 174,43 € | 10,75 % |
| Neurocrine Bioscience | 32 | 0 | 3 | 0 | 126,60 € | 140,87 € | 11,27 % |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | 116,40 € | 130,00 € | 11,68 % |
| Merck & Co. Inc. | 30 | 1 | 2 | 0 | 121,00 € | 124,97 € | 3,28 % |
| Abbott Laboratories | 18 | 0 | 2 | 0 | 96,84 € | 116,48 € | 20,28 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | 78,42 € | 102,62 € | 30,86 % |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | 68,84 € | 100,00 € | 45,26 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | 36,60 € | 85,51 € | 133,64 % |
| Gilead Sciences Inc | 11 | 1 | 0 | 0 | 60,78 € | 84,81 € | 39,54 % |
| Cytokinetics Inc. | 32 | 1 | 6 | 0 | 49,20 € | 83,21 € | 69,12 % |
| Intra-Cellular Therapies Inc. | 27 | 0 | 3 | 0 | 63,50 € | 79,55 € | 25,28 % |
| Incyte Corp. | 12 | 2 | 0 | 0 | 58,02 € | 78,05 € | 34,52 % |